心血管医学的十字路口:进步和影响的障碍
Jessica A Regan1,2, Melissa H Laitner3, Victor J Dzau1,3,4
1Division of Cardiology (J.A.R., V.J.D.), Duke University School of Medicine, Durham, NC.
Circulation
|October 20, 2025
概括
心血管医学取得了重大进展, 但由于实施缺陷, 减少死亡率的进展停滞不前. 未来的努力必须优先考虑预防和公平获取新疗法.
科学领域:
- 心血管医学与技术
- 分子医学
- 医疗服务研究
背景情况:
- 75年来心血管科学取得的重大进展减少了患病率和死亡率.
- 从1950年至2010年间,具有里程碑意义的创新有助于降低心血管死亡率.
- 最近的进展包括新的药物疗法,干预程序,手术技术和分子医学 (基因编辑,基于RNA的治疗).
研究的目的:
- 检查过去15年心血管医学的进展.
- 找出最近心血管死亡率改善的原因.
- 提出未来心血管医学进步的路线图.
主要方法:
- 对心血管医学的科学文献和技术发展进行回顾.
- 对心血管疾病和死亡率趋势的分析.
- 检查实施科学和医疗保健提供模式.
主要成果:
- 尽管有创新, 心血管疾病死亡率的改善却停滞不前.
- 流行病学转变和持续的实施不平等是停滞不前的关键因素.
- 新的分子医学方法有前途, 但需要有效的交付.
结论:
- 未来心血管医学的进步需要不仅关注创新,还需要强有力的预防策略.
- 负责任的创新和周到的医疗保健服务对于将进步转化为改善人口健康结果至关重要.
- 解决健康不平等问题至关重要,以确保所有人都能从心血管医学进步中受益.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
212
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
212
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Coronary Artery Disease I: Introduction
876
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
876
Cardiomyopathy V: Interprofessional Care
335
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
Regulation of the Cardiovascular System
3.6K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.6K
Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K


